Valeant close to $1 billion deal for maker of women’s libido drug
August 20, 2015 at 06:15 AM EDT
Valeant is nearing a deal to pay $1 billion for the company that just won approval to sell a drug aimed at boosting a woman’s libido.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.